Nutritional Recommendations for Patients With Heart Failure

Journal of Cardiovascular Nursing

Volumn 21, Issue 4, 2006, Pages 261-268

  Lennie, Terry A ^a  

^a UNIVERSITY OF KENTUCKY COLLEGE OF NURSING   (United States)

Author keywords

Heart failure; Nutritional requirements; Obesity paradox

Indexed keywords

OMEGA 3 FATTY ACID; SERUM ALBUMIN; TRACE ELEMENT;

BODY MASS; CONGESTIVE HEART FAILURE; DIET SUPPLEMENTATION; DIET THERAPY; HUMAN; NUTRITION; NUTRITIONAL ASSESSMENT; PROTEIN INTAKE; REVIEW;

BODY MASS INDEX; DIETARY PROTEINS; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; HEART FAILURE, CONGESTIVE; HUMANS; MICRONUTRIENTS; NUTRITION ASSESSMENT; NUTRITION PHYSIOLOGY; SERUM ALBUMIN;

EID: 33748640122     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/00005082-200607000-00005     Document Type: Article

References (71)

1. Berry C, Clark AL. Catabolism in chronic heart failure. Eur Heart J. 2000;21:521-532.
2. Silver MA. Dietary research in heart failure: beyond the salt shaker. J Am Coll Cardiol. 2003;42:1224-1225.
3. Conraads VM, Bosmans JM, Vrints CJ. Chronic heart failure: an example of a systemic chronic inflammatory disease resulting in cachexia. Int J Cardiol. 2002;85:33-49.
4. Mann DL. Activation of inflammatory mediators in heart failure. In: Mann DL, ed. Heart Failure. Philadelphia: WB Saunders; 2004:159-180.
5. Milani RV, Mehra MR, Endres S, et al. The clinical relevance of circulating tumor necrosis factor-alpha in acute decompensated chronic heart failure without cachexia. Chest. 1996;110:992-995.
6. Lommi J, Pulkki K, Koskinen P, et al. Haemodynamic, neuroendocrine and metabolic correlates of circulating cytokine concentrations in congestive heart failure. Eur Heart J. 1997;18:1620-1625.
7. Katz SD, Rao R, Berman JW, et al. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Relation to nitric oxide-dependent vasodilation in the forearm circulation. Circulation. 1994;90:12-16.
8. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323:236-241.
9. Munger MA, Johnson B, Amber IJ, Callahan KS, Gilbert EM. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1996;77:723-727.
10. Aukrust P, Ueland T, Lien E, et al. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1999;83:376-382.
11. Heart Failure Society of America (HFSA) practice guidelines. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction-pharmacological approaches. J Card Fail. 1999;5:357-382.
12. Aquilani R, Opasich C, Verri M, et al. Is nutritional intake adequate in chronic heart failure patients? J Am Coll Cardiol. 2003;42:1218-1223.
13. Gorelik O, Almoznino-Sarafian D, Feder I, et al. Dietary intake of various nutrients in older patients with congestive heart failure. Cardiology. 2003;99:177-181.
14. Costello RB, Moser-Veillon PB, DiBianco R. Magnesium supplementation in patients with congestive heart failure. J Am Coll Nutr. 1997;16:22-31.
15. Witte KK, Clark AL, Cleland JG. Chronic heart failure and micronutrients. J Am Coll Cardiol. 2001;37:1765-1774.
16. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes FaNB; Institute of Medicine. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. Washington, DC: National Academies Press; 1997.
17. Office of Dietary Supplements, Health NIo. Vitamin E. March 2005. Available at:. Accessed October 2005.
18. Office of Dietary Supplements, Health NIo. Vitamin E. March 2005. Available at:. Accessed October 2005.
19. Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142:37-46.
20. Keith ME, Jeejeebhoy KN, Langer A, et al. A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure. Am J Clin Nutr. 2001;73:219-224.
21. Lonn E, Bosch J, Yusuf S, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA. 2005;293:1338-1347.
22. Institute of Medicine. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academic Press; 1998.
23. Das UN. Folic acid says NO to vascular diseases. Nutrition. 2003;19:686-692.
24. Wilson P. Homocysteine, vitamins, and cardiovascular disease. Medscape. Available at:. Accessed January 20, 2004.
25. Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academic Press; 2000.
26. Pasini E, Aquilani R, Gheorghiade M, Dioguardi FS. Malnutrition, muscle wasting and cachexia in chronic heart failure: the nutritional approach. Ital Heart J. 2003;4:232-235.
27. Demling RH, DeSanti L. Involuntary weight loss and protein-energy malnutrition: diagnosis and treatment. Medscape. Available at:. Accessed May 15, 2006.
28. Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Protein, Amino Acids (Macronutrients). Washington, DC: Academic Press; 2002.
29. Heller AR, Theilen HJ, Koch T. Fish or chips? News Physiol Sci. 2003;18:50-54.
30. Calder PC. Immunoregulatory and anti-inflammatory effects of n-3 polyunsaturated fatty acids. Braz J Med Biol Res. 1998;31:467-490.
31. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002;56:365-379.
32. McCarty MF. Fish oil and other nutritional adjuvants for treatment of congestive heart failure. Med Hypotheses. 1996;46:400-406.
33. Sole MJ, Jeejeebhoy KN. Conditioned nutritional requirements and the pathogenesis and treatment of myocardial failure. Curr Opin Clin Nutr Metab Care. 2000;3:417-424.
34. Rosenfeldt F, Hilton D, Pepe S, Krum H. Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure. Biofactors. 2003;18:91-100.
35. Pauly DF, Pepine CJ. The role of carnitine in myocardial dysfunction. Am J Kidney Dis. 2003;41:S35-S43.
36. Schaffer SW, Lombardini JB, Azuma J. Interaction between the actions of taurine and angiotensin II. Amino Acids. 2000;18:305-318.
37. WHO. Obesity: preventing and managing the global epidemic. WHO Technical Report Series, No. 894. Geneva, Switzerland: World Health Organization; 1997.
38. Anker SD, Coats AJ. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. Chest. 1999;115:836-847.
39. Anker SD, Ponikowski P, Varney S, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 1997;349:1050-1053.
40. Davos CH, Doehner W, Rauchhaus M, et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail. 2003;9:29-35.
41. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol. 2001;38:789-795.
42. Lavie CJ, Osman AF, Milani RV, Mehra MR. Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol. 2003;91:891-894.
43. Mosterd A, Cost B, Hoes AW, et al. The prognosis of heart failure in the general population: The Rotterdam Study. Eur Heart J. 2001;22:1318-1327.
44. Fonarow GC, Horwich TB. Obesity, weight reduction and survival in heart failure: reply. J Am Coll Cardiol. 2002;39:1563-1564.
45. Mohamed-Ali V, Goodrick S, Bulmer K, Holly JM, Yudkin JS, Coppack SW. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol. 1999;277:E971-E975.
46. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest. 2000;117:1162-1172.
47. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305-313.
48. Willett WC, Dietz WH, Colditz GA. Guidelines for healthy weight. N Engl J Med. 1999;341:427-434.
49. Jensen MD. Health consequences of fat distribution. Horm Res. 1997;48(suppl 5):88-92.
50. Kenchaiah S, Gaziano JM, Vasan RS. Impact of obesity on the risk of heart failure and survival after the onset of heart failure. Med Clin North Am. 2004;88:1273-1294.
51. Yan LL, Daviglus ML, Liu K, et al. Midlife body mass index and hospitalization and mortality in older age. JAMA 2nd ed. Academic Press;2006;295:190-198.
52. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA. 2003;289:187-193.
53. Kyle UG, Genton L, Pichard C. Hospital length of stay and nutritional status. Curr Opin Clin Nutr Metab Care. 2005;8:397-402.
54. Anker SD, Steinborn W, Strassburg S. Cardiac cachexia. Ann Med. 2004;36:518-529.
55. Blackburn GL, Gibbons GW, Bothe A, Benotti PN, Harken DE, McEnany TM. Nutritional support in cardiac cachexia. J Thorac Cardiovasc Surg. 1977;73:489-496.
56. Nicol SM, Carroll DL, Homeyer CM, Zamagni CM. The identification of malnutrition in heart failure patients. Eur J Cardiovasc Nurs. 2002;1:139-147.
57. Toth MJ, Gottlieb SS, Goran MI, Fisher ML, Poehlman ET. Daily energy expenditure in free-living heart failure patients. Am J Physiol. 1997;272:E469-E475.
58. Carr JG, Stevenson LW, Walden JA, Heber D. Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1989;63:709-713.
59. Moser DK, Lennie TA, Doering LV. Non-pharmacologic management of heart failure. In: Stewart S, Moser DK, Thompson DR, eds. Caring for the Heart Failure Patient. A Textbook for the Health Care Professional. London: Martin Dunitz; 2000:115-132.
60. Prealbumin in Nutritional Care Consensus Group. Measurement of visceral protein status in assessing protein and energy malnutrition: standard of care. Nutrition. 1995;11:169-171.
61. Lennie TA, Chung ML, Habash DL, Moser DK. Dietary fat intake and proinflammatory cytokine levels in patients with heart failure. J Card Fail. 2005;11:613-618.
62. Institute of Medicine. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academic Press; 1997.
63. Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academic Press; 2001.
64. Institute of Medicine. Dietary Reference Intakes. Applications in Dietary Assessment. Washington, DC: National Academic Press; 2000.
65. Institute of Medicine. Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate. Washington, DC: National Academic Press; 2000.
66. United States Department of Agriculture. Dietary guidelines for Americans 2005. Available at:. Accessed May 15, 2006.
67. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Commitee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Available at:. Accessed September 2005.
68. Krauss RM, Eckel RH, Howard B, et al. AHA Dietary Guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation. 2000;102:2284-2299.
69. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106:2747-2757.
70. Benatti P, Peluso G, Nicolai R, Calvani M. Polyunsaturated fatty acids: biochemical, nutritional and epigenetic properties. J Am Coll Nutr. 2004;23:281-302.
71. Dubnov G, Berry EM. Omega-6 fatty acids and coronary artery disease: the pros and cons. Curr Atheroscler Rep. 2004;6:441-446.